Login / Signup
Manyi Xu
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Tyrosine Kinase
Advanced Non Small Cell Lung Cancer
Top Venues
Cancer medicine
Investigational new drugs
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lan Xu
,
Manyi Xu
,
Wei Sun
,
Weiping Zhang
,
Zhengbo Song
Clinical characteristics and prognostic impact of immune checkpoint inhibitor-associated myocarditis in advanced non-small cell lung cancer.
Investigational new drugs
(2023)
Yue Hao
,
Manyi Xu
,
Jianan Jin
,
Jinfei Si
,
Chun-Wei Xu
,
Zhengbo Song
Comparison of efficacy and safety of second- and third-generation TKIs for non-small-cell lung cancer with uncommon EGFR mutations.
Cancer medicine
(2023)